Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Hongkee Sah,1,2 Laura A Thoma,2 Hari R Desu,2 Edel Sah,3 George C Wood21College of Pharmacy, Ewha Womans University, Sedaemun-gu, Seoul, South Korea; 2College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA; 3College of Science, University of Notre Dame, Notre Dame,...
Guardado en:
Autores principales: | Sah H, Thoma LA, Desu HR, Sah E, Wood GC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e911acd158e4dfd8c0df827cbd733e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
por: Jahan ST, et al.
Publicado: (2018) -
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
por: Bhatt PC, et al.
Publicado: (2017) -
Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel
por: Sultan Alshehri, et al.
Publicado: (2021) -
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
por: Tan W, et al.
Publicado: (2011) -
Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier
por: Cheng G, et al.
Publicado: (2012)